Expand CURX Menu
CURX MENU

CURX Latest Press Releases

-- May 14, 2026 --

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission Globe Newswire 8:53 AM

-- May 12, 2026 --

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) PRNewswire 6:08 PM

-- April 30, 2026 --

CURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firm Globe Newswire 8:35 PM

-- April 16, 2026 --

Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - CURX Business Wire 10:55 AM

-- April 8, 2026 --

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline Globe Newswire 7:47 AM

-- April 6, 2026 --

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care Globe Newswire 9:17 AM

-- April 2, 2026 --

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company's Evolution Into a Broader Therapeutics Development Company Globe Newswire 8:07 AM

-- March 30, 2026 --

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission Globe Newswire 5:35 PM

-- March 18, 2026 --

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission Globe Newswire 8:00 AM

-- March 12, 2026 --

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers Globe Newswire 9:30 AM

-- March 11, 2026 --

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board Globe Newswire 8:00 AM

-- March 5, 2026 --

Curanex Forms World Class Scientific Advisory Board Globe Newswire 8:00 AM

-- February 25, 2026 --

Curanex Provides Operational Update on Key Regulatory Milestones Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes